Delivery Order SPE2D021DA002-SPE2D324F110A

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.6K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of TWINRIX vaccine syringes to the DLA. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, to provide a comprehensive range of pharmaceutical items to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,636.62 order is for the delivery of 4,567,978,112 units of the TWINRIX VACCINE SYRINGE. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) awarded to DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the TWINRIX vaccine in syringes. The contract, valued at $2,454.93, has a performance period through May 15, 2025. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and DLA under the SPE2DB program, which enables the agency to order a range of pharmaceutical...
This firm fixed price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the supply of TWINRIX vaccine syringes, with a potential value of $2,798.52. This order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with the Defense Logistics Agency to provide a variety of pharmaceutical items and medical supplies to military treatment facilities...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $1,602.92 and is for the delivery of the TWINRIX vaccine syringe to military health facilities. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999,...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,602.92, is for the delivery of 4,565,118,241 units of the TWINRIX vaccine syringe. The contract has an ultimate completion date of July 12, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc. with the DLA under the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business. The order, valued at $2,347.29, is for the supply of the TWINRIX VACCINE SYRINGE. The delivery order was issued under a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA to provide a variety of pharmaceutical items and medical supplies to military treatment facilities worldwide....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,636.62, is for the delivery of 4,568,085,988 units of the TWINRIX vaccine syringe. The contract has a period of performance through May 1, 2025. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide the TWINRIX vaccine in syringe form. The delivery order, valued at $1,602.92, is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group Inc. and DLA, contract number SPE2DB-13-D-4600, with a ceiling value of up to $4,999,999 through 2025. This IDC enables DLA to issue firm fixed-price...
This is a $8,014.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of TWINRIX vaccine syringes to support the medical supply needs of military healthcare facilities. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
  • SPE2D021DA002
    Indefinite Delivery Contract
  • SPE2D021DA002-SPE2D324F110A
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to the woman-owned small business DMS Pharmaceutical Group Inc. The contract, valued at $1,602.92, is for the delivery of the TWINRIX vaccine syringe. This award is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued up to $499,999,999, which provides a wide range of pharmaceutical products to support military medical facilities worldwide. The contract does not have a set-aside designation. Through this vehicle, DMS Pharmaceutical Group supplies a comprehensive array of branded, generic, and specialized medications, biologics, and medical consumables to the Department of Defense (DoD) and Department of Veterans Affairs (VA).

Generated 10/11/24, 9:19 AM